Linezolid lock prophylaxis of central venous catheter infection
Fennell, J. P. O'Donohoe, M. Cormican, M. Lynch, M.
Fennell, J. P.
O'Donohoe, M.
Cormican, M.
Lynch, M.
Citations
Altmetric
item.page.identifiers
Date
2008-04-01
item.page.type
journal article
item.page.downloads
Citation
Fennell, J. P. O'Donohoe, M.; Cormican, M.; Lynch, M. (2008). Linezolid lock prophylaxis of central venous catheter infection. Journal of Medical Microbiology 57 (4), 534-535
Abstract
Central venous catheter (CVC)-related infections are a major problem for patients requiring long-term venous access and may result in frequent hospital admissions and difficulties in maintaining central venous access. CVC-related blood stream infections are associated with increased duration of inpatient stay and cost approximately (sic) 13 585 per patient [Blot, S. I., Depuydt, P., Annemans, L., Benoit, D., Hoste, E., De Waele, J. J., Decruyenaere, J., Vogelaers, D., Colardyn, F. & Vandewoude, K. H. (2005). Clin Infect Dis 41, 1591-1598]. Antimicrobial lock therapy may prevent CVC-related blood stream infection, preserve central venous access and reduce hospital admissions. In this paper, the impact of linezolid lock prophylaxis in a patient with short bowel syndrome is described.
item.page.funder
Publisher
Microbiology Society